Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy.
Cellerix is leading the development of a new generation of treatments using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials Phase I and II have been very promising.
Meet us at...
-
ISCT Europe Regional Meeting - Antwerp, Belgium - 14th to 16th September 2008
-
BIOSPAIN 2008 - Granada, Spain - 17th to 19th September 2008
- see more events.